Tag Archive: idiopathic short stature

Mar 21 2019

Digging Deep Into Decisions to Treat Short Stature With Human Growth Hormone

By Nancy McCann

Tall people are self-confident, successful, and have the world at their feet, according to our society’s biases and assumptions. This perception tends to elevate the pressure for parents, children, and clinicians to try human growth hormone (hGH) for treating idiopathic short stature (ISS) — children with severe short stature without an identifiable cause. But how short is severe enough to warrant hGH treatment, which can involve years of daily injections and exposure to potential side effects, at a cost of about $30,000 per patient per year?

Read the rest of this entry >>

Feb 10 2017

CHOP Research In the News: Growth Failure, Glucose Target Ranges, CHIP Funding, Global Road Safety

CHOP Research In the NewsWe’ve had a flurry of activity this week at Children’s Hospital of Philadelphia Research Institute, including our first snowstorm of the year. In between shoveling, we took a few minutes to dig into the latest research news.

Read the rest of this entry >>

Jul 2 2015

Study Finds Gender Bias in Growth Hormone Treatment for Height

growth hormoneResearchers from The Children’s Hospital of Philadelphia have found a gender bias in the provision of treatment for idiopathic short stature with recombinant human growth hormone treatment.

Read the rest of this entry >>